JP2005006777A - Tube for medical use - Google Patents
Tube for medical use Download PDFInfo
- Publication number
- JP2005006777A JP2005006777A JP2003172601A JP2003172601A JP2005006777A JP 2005006777 A JP2005006777 A JP 2005006777A JP 2003172601 A JP2003172601 A JP 2003172601A JP 2003172601 A JP2003172601 A JP 2003172601A JP 2005006777 A JP2005006777 A JP 2005006777A
- Authority
- JP
- Japan
- Prior art keywords
- tube
- medical tube
- base material
- group
- reactive group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
【0001】
【発明の属する技術分野】
本発明は、輸液・輸血などに用いる回路において、適度な柔軟性をもった医療用チューブに関する。
【0002】
【従来の技術】
従来、輸液・輸血の際用いられる回路においては、多くは、ジ−2エチルヘキシルフタレート(DEHP)可塑化PVCが使用されている。しかしながら、PVCはその可塑剤DEHPの溶出が問題となり、脂肪乳剤やタキソール等、DEHP可塑化PVCを使用することを禁じている薬剤があり、可塑剤を含まない軟質ポリオレフィンを用いた製品が散見される。
【0003】
しかしながら、これらのポリオレフィンは疎水性が高いため、チューブ内を液体が流れる際、液体の溶存気体等から発生する気泡が一旦付着すると、その気泡が下流に流れにくくなり、輸液・輸血ラインのプライミングの困難さや、付着した気泡が輸液ポンプ等の気泡センサーに検出され、不具合を生じることがある。
【0004】
【特許文献1】
特開平1−250265号公報
【0005】
【発明が解決しようとする課題】
本発明は、上記のような従来技術が有する欠点、即ち気泡の付着を抑制した可塑剤を含まない医療用チューブを提供することにある。
【0006】
【課題を解決するための手段】
本発明において、以下に記載する方法、或いはその方法によって得られた医療用チューブによって、上記の課題を解決できた。即ち、本発明の第1は、合成高分子からなる基材が、少なくともその構成成分の一部に反応基を有しており、該反応基の少なくとも一部を利用して水酸基を導入することによって、親水性を改善したことを特徴とする医療用チューブに関する。
【0007】
さらに、本発明の第2は、少なくともその構成成分の一部に反応基を有する合成高分子の基材表面を酸、またはアルカリによって処理し、前記反応基の少なくとも一部を加水分解することによって、水酸基に置換することを特徴とする医療用チューブの表面改質方法に関する。
【0008】
本発明において、基材の有する反応基(カルボキシル基やイソシアネート基、アミノ基、アミン、エステル、等の反応性に富んだ基)を酸、アルカリ処理することで、上記反応基が加水分解され、水酸基に置換される。この置換は、特に基材表面に偏在し、内部深くまで浸透しない。それによって、基材の有する柔軟性や透明性などの物理特性は(適度に)維持されながら、基材表面の親水性が改善される。
【0009】
親水性が向上することによって、チューブの通液時における気泡の付着が抑制される。また、本考案による濡れ性の改善は、化学的に官能基を導入するため、ポリマーに低分子界面活性剤のような第2成分を添加する方法のように、添加剤のブルームやブリードがなく、医療用途として安安全性が高いものとなる。
【0010】
本発明は、上記の構成をもとに以下に示すような様々な実施形態を取ることができ、それぞれに特有な効果を得ることができる。
【0011】
1つの例として、前記水酸基の導入が、基材内部より、基材表面の方が多いものである前記医療用チューブである。それによって、前述したような基材の物性変化が抑制できる。
【0012】
或いは、前記合成高分子の反応基がカルボキシル基であり、該カルボキシル基の少なくとも一部が、水酸基に置換された前記医療用チューブである。酸またはアルカリ処理によって、極めて容易に親水性が改善できる。しかも、反応基自体の安全性も高い。
【0013】
また、チューブ材質がエチレン−酢酸ビニル共重合体(以下、EVAともいう)から成る医療用チューブで、親水性を改善した基材表面が接触角75度以下である前記の医療用チューブである。上記基材は使用する際、柔軟性、加工性、透明度の点で優れており、且つチューブ表面(内腔)が濡れ易いので、気泡が付着し難い。
【0014】
【発明の実施の形態】
本考案の表面処理の方法は、EVA表面のカルボキシル基を加水分解することで、水酸基に変換することである。加水分解の方法は、アルカリによる加水分解が、その効果の上で特に望ましい。処理溶液のpH調整はKOH、NaOHなど特に限定はされないが、pH7.0〜12、処理温度25〜70℃、処理時間5〜480分でEVA表面のカルボキシル基が効率的に水酸基に変換される。好ましくは、pH7.5〜9.5、処理温度40〜50℃、処理時間60〜180分である。
【0015】
上記の条件によって、カルボキシル基の水酸基への置換割合、即ち鹸化度は5〜25%となる。また、上記の条件によって、鹸化の行われる部位が、チューブ肉厚の8〜15%程度になるため、基材の物性を維持したまま、親水性が改善できる。
【0016】
これよりpHや処理温度が低く処理時間が短い場合は、水酸基への変換が十分ではなく、適当な濡れ性を得られない場合がある。またpHや処理温度が高く処理時間が長い場合は、水酸基への変換がチューブ内部まで進行し、チューブが硬くなったり、通液の際、液体がチューブ内部まで浸透し、チューブの透明性を阻害する。
【0017】
【実施例】
1.サンプルの作製
(1)実施例
EVA(ウルトラセンYX11C、東ソー株式会社)を30mm押出し成型機(L/D=26)を用いて、成型温度170〜180℃で、内径×外径=2.5×3.8mmのチューブを成型した。得られたEVAチューブ内腔に、50℃に温調した水酸化カリウムのアルコール溶液(1Mエタノール性水酸化カリウム、和光純薬工業株式会社)を1時間及び3時間循環し、それぞれ実施例▲1▼及び実施例▲2▼とした。
【0018】
(2)比較例
実施例で成型したEVAチューブを、実施例と同様の方法で24時間処理したチューブを比較例▲1▼とした。また未処理のEVAチューブを比較例▲2▼とした。
【0019】
2.実験
(1)鹸化度の測定
上記チューブの鹸化度の測定は、以下の方法によって行った。上記の各チューブ1.0グラムに、0.05mol/Lの硫酸水溶液を30ml加えて、振り混ぜる。その後、指示薬として、フェノールフタレン溶液を加え、0.1mol/Lの水酸化ナトリウム水溶液で滴定することによって、EVAチューブにおけるビニルアルコール(Binyl−OH基)の割合、即ち鹸化度を測定した。
【0020】
(2)親水性評価1
実施例▲1▼、▲2▼及び比較例▲1▼、▲2▼で作製したチューブの内腔表面の接触角を測定することで、チューブ内の水酸基の導入、即ち水濡れ性を評価した。実施例▲1▼及び▲2▼、比較例▲1▼と処理時間が長くなるほど、接触角は小さくなり、水濡れ性が向上していることが示唆された。また、未処理の比較例▲2▼は最も接触角が高かった。
【0021】
(3)親水性評価2
実施例▲1▼、▲2▼及び比較例▲1▼、▲2▼で作製したチューブを引張り試験機にて、速度50mm/hで引張ったときの、初期弾性率は、実施例▲1▼、▲2▼は、未処理EVAである比較例▲2▼とほとんど同じ値を示し、柔軟性を維持していたが、比較例▲1▼は高値を示し、チューブが硬くなっていた。
【0022】
(4)親水性評価3
実施例▲1▼、▲2▼及び比較例▲1▼、▲2▼で作製したチューブで輸液セットを組みたて、エチレン・オキサイドガス滅菌後、定法により生食バッグを接続して、落差1mにて、ローラー式流量調節器にて点滴速度80mL/hで輸液を行った。目視でチューブを観察したところ、実施例▲1▼、▲2▼及び比較例▲1▼のチューブには気泡の付着は殆ど見られなかったが、比較例▲1▼のチューブでは輸液時間の経過とともにチューブが白濁してきた。
【0023】
また、輸液停止をローラー式流量調節器で実施したところ、比較例▲1▼ではチューブが硬すぎ、完全に停止することができなかった。比較例▲2▼のチューブでは、点滴筒とチューブの接続部や流量調節器下部付近に気泡の付着が顕著に見られた。
【0024】
【表1】
【0025】
【発明の効果】
上記構成の医療用チューブは、チューブ内腔に液体を流した際、速やかに濡れ、気泡が下流に流れることで、プライミングが容易となる。また、通液の際、液体中の溶存気体が気泡として発生しても、気泡が付着しにくくなっており、結果的に輸液・輸血ラインに接続した装置の気泡センサーや人体に影響を及ぼすような気泡の発生が認められない。[0001]
BACKGROUND OF THE INVENTION
The present invention relates to a medical tube having appropriate flexibility in a circuit used for infusion or blood transfusion.
[0002]
[Prior art]
Conventionally, di-2 ethylhexyl phthalate (DEHP) plasticized PVC is often used in circuits used for transfusion and blood transfusion. However, PVC has a problem of elution of its plasticizer DEHP, and there are drugs that prohibit the use of DEHP plasticized PVC such as fat emulsion and taxol, and there are some products using soft polyolefins that do not contain plasticizer. The
[0003]
However, since these polyolefins are highly hydrophobic, once the liquid flows in the tube, once the bubbles generated from the dissolved gas in the liquid adhere to the tube, it becomes difficult for the bubbles to flow downstream. Difficulties and attached air bubbles may be detected by air bubble sensors such as infusion pumps, causing problems.
[0004]
[Patent Document 1]
JP-A-1-250265
[Problems to be solved by the invention]
An object of the present invention is to provide a medical tube that does not contain a plasticizer that suppresses the drawbacks of the above-described prior art, that is, the adhesion of bubbles.
[0006]
[Means for Solving the Problems]
In the present invention, the above-described problems can be solved by the method described below or a medical tube obtained by the method. That is, according to the first aspect of the present invention, a base material made of a synthetic polymer has a reactive group in at least a part of its constituent components, and a hydroxyl group is introduced using at least a part of the reactive group. It is related with the medical tube characterized by having improved hydrophilicity by.
[0007]
Furthermore, the second of the present invention is to treat at least a part of the reactive group by treating the surface of the base material of the synthetic polymer having a reactive group at least part of its constituents with an acid or alkali. The present invention also relates to a method for modifying the surface of a medical tube, wherein the surface is substituted with a hydroxyl group.
[0008]
In the present invention, the reactive group is hydrolyzed by treating the reactive group (carboxyl group, isocyanate group, amino group, amine, ester, and other reactive groups) with an acid or alkali, Substituted with a hydroxyl group. This substitution is particularly ubiquitous on the substrate surface and does not penetrate deep into the interior. Thereby, the hydrophilicity of the substrate surface is improved while maintaining (moderately) the physical properties of the substrate such as flexibility and transparency.
[0009]
By improving the hydrophilicity, bubbles are prevented from adhering when the tube is passed through. In addition, the improvement of wettability according to the present invention is that there is no additive bloom or bleed as in the method of adding a second component such as a low-molecular surfactant to the polymer in order to introduce a functional group chemically. As a medical application, safety is high.
[0010]
The present invention can take various embodiments as described below based on the above-described configuration, and can obtain unique effects.
[0011]
As one example, in the medical tube, introduction of the hydroxyl group is more on the surface of the base material than in the base material. Thereby, the physical property change of the base material as described above can be suppressed.
[0012]
Alternatively, in the medical tube, a reactive group of the synthetic polymer is a carboxyl group, and at least a part of the carboxyl group is substituted with a hydroxyl group. Hydrophilicity can be improved very easily by acid or alkali treatment. Moreover, the safety of the reactive group itself is high.
[0013]
Further, in the medical tube, the tube material is made of an ethylene-vinyl acetate copolymer (hereinafter also referred to as EVA), and the surface of the base material with improved hydrophilicity has a contact angle of 75 degrees or less. When used, the substrate is excellent in flexibility, processability, and transparency, and the tube surface (lumen) is easily wetted, so that bubbles are difficult to adhere.
[0014]
DETAILED DESCRIPTION OF THE INVENTION
The surface treatment method of the present invention is to convert the carboxyl group on the EVA surface into a hydroxyl group by hydrolyzing it. As the hydrolysis method, alkali hydrolysis is particularly desirable in view of its effect. The pH adjustment of the treatment solution is not particularly limited, such as KOH and NaOH, but the carboxyl group on the EVA surface is efficiently converted to a hydroxyl group at a pH of 7.0 to 12, a treatment temperature of 25 to 70 ° C., and a treatment time of 5 to 480 minutes. . Preferably, the pH is 7.5 to 9.5, the treatment temperature is 40 to 50 ° C., and the treatment time is 60 to 180 minutes.
[0015]
Under the above conditions, the substitution ratio of the carboxyl group to the hydroxyl group, that is, the saponification degree is 5 to 25%. Moreover, since the site | part to which saponification is performed will be about 8 to 15% of tube thickness by said conditions, hydrophilicity can be improved, maintaining the physical property of a base material.
[0016]
If the pH or the treatment temperature is lower than this and the treatment time is short, the conversion to a hydroxyl group is not sufficient, and appropriate wettability may not be obtained. In addition, when the pH and processing temperature are high and the processing time is long, the conversion to the hydroxyl group proceeds to the inside of the tube, and the tube becomes hard or the liquid penetrates to the inside of the tube when passing, impeding transparency of the tube To do.
[0017]
【Example】
1. Preparation of sample (1) Example EVA (Ultrasen YX11C, Tosoh Corporation) using a 30 mm extrusion molding machine (L / D = 26) at a molding temperature of 170 to 180 ° C., inner diameter × outer diameter = 2.5 A x3.8 mm tube was molded. An alcohol solution of potassium hydroxide (1M ethanolic potassium hydroxide, Wako Pure Chemical Industries, Ltd.) adjusted to 50 ° C. was circulated in the lumen of the obtained EVA tube for 1 hour and 3 hours. And Example (2).
[0018]
(2) Comparative Example The EVA tube molded in the example was treated for 24 hours in the same manner as in the example, and the tube was designated as comparative example (1). An untreated EVA tube was used as Comparative Example (2).
[0019]
2. Experiment (1) Measurement of degree of saponification The degree of saponification of the above tube was measured by the following method. Add 30 ml of 0.05 mol / L sulfuric acid aqueous solution to 1.0 gram of each tube and shake. Thereafter, a phenolphthalene solution was added as an indicator, and titration was performed with a 0.1 mol / L sodium hydroxide aqueous solution to measure the ratio of vinyl alcohol (Binyl-OH group) in the EVA tube, that is, the degree of saponification.
[0020]
(2) Hydrophilic evaluation 1
The introduction of hydroxyl groups in the tube, that is, water wettability was evaluated by measuring the contact angle of the lumen surface of the tubes prepared in Examples (1) and (2) and Comparative Examples (1) and (2). . It was suggested that the longer the treatment time with Examples (1) and (2) and Comparative Example (1), the smaller the contact angle and the better the water wettability. The untreated comparative example (2) had the highest contact angle.
[0021]
(3) Hydrophilic evaluation 2
The initial elastic modulus when the tubes prepared in Examples (1) and (2) and Comparative Examples (1) and (2) were pulled at a speed of 50 mm / h with a tensile tester was determined in Example (1). , (2) showed almost the same value as Comparative Example (2), which was untreated EVA, and maintained flexibility, but Comparative Example (1) showed a high value, and the tube was hard.
[0022]
(4) Hydrophilic evaluation 3
After constructing an infusion set with the tubes prepared in Example (1), (2) and Comparative Examples (1), (2), after sterilization with ethylene oxide gas, connect a saline bag by a conventional method to reduce the drop to 1 m Then, infusion was performed at a drip rate of 80 mL / h using a roller-type flow controller. When the tube was visually observed, almost no bubbles were observed in the tubes of Examples (1), (2) and Comparative Example (1), but the infusion time elapsed in the tube of Comparative Example (1). At the same time, the tube became cloudy.
[0023]
Further, when the infusion was stopped with a roller-type flow controller, in Comparative Example (1), the tube was too hard to be completely stopped. In the tube of Comparative Example (2), air bubbles were noticeably observed in the vicinity of the connecting portion of the drip tube and the tube and the lower part of the flow rate controller.
[0024]
[Table 1]
[0025]
【The invention's effect】
The medical tube having the above-described configuration is easily primed when a liquid is allowed to flow through the tube lumen, so that the air bubbles quickly flow downstream. In addition, even if dissolved gas in the liquid is generated as a bubble when liquid is passed, it is difficult for the bubble to adhere, and as a result, it may affect the bubble sensor of the device connected to the infusion / transfusion line and the human body. Generation of bubbles is not observed.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003172601A JP2005006777A (en) | 2003-06-17 | 2003-06-17 | Tube for medical use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003172601A JP2005006777A (en) | 2003-06-17 | 2003-06-17 | Tube for medical use |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2005006777A true JP2005006777A (en) | 2005-01-13 |
Family
ID=34096682
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003172601A Pending JP2005006777A (en) | 2003-06-17 | 2003-06-17 | Tube for medical use |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2005006777A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012251090A (en) * | 2011-06-03 | 2012-12-20 | Nihon Univ | Apparatus and method for treating inside surface of tube |
-
2003
- 2003-06-17 JP JP2003172601A patent/JP2005006777A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012251090A (en) * | 2011-06-03 | 2012-12-20 | Nihon Univ | Apparatus and method for treating inside surface of tube |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2012169081A1 (en) | Vinyl chloride resin composition | |
TW403664B (en) | Oriented medical tubing | |
US9446216B2 (en) | Cannular device and method of manufacture | |
US4177182A (en) | Polyvinyl chloride series resin medical product implements and method of manufacturing the same using siloxane oil additive | |
CN101962461B (en) | Phthalate-free medical polrvinyl chloride (PVC) plastic | |
JP2005006777A (en) | Tube for medical use | |
CN103989661A (en) | Sildenafil oral instant membrane and preparation method thereof | |
CN110694118A (en) | Antibacterial and anticoagulant ventricles and abdominocentesis shunt tube silica gel tube body and preparation method and application thereof | |
JP2005040397A (en) | Catheter | |
JP4419448B2 (en) | Medical tube | |
JPS6128541A (en) | Vinyl chloride resin composition for medical equipment | |
JP3192217B2 (en) | Medical tubing | |
JPS5933343A (en) | Vinyl chloride resin composition | |
JPS587298B2 (en) | Method for manufacturing medical molded products made of vinyl ester synthetic resin with hydrophilic surface | |
JP2006061226A (en) | Catheter having connector | |
JP6386246B2 (en) | Blood coagulation promoter, blood collection container, and method for measuring thyroid stimulating hormone | |
CN105949669A (en) | Low-precipitation medical plastic catheter material and preparation method thereof | |
CN107718587B (en) | A kind of multifunctional medical conduit and preparation method thereof, application | |
CN103826666B (en) | For forming interim ileac compositions | |
CN105061928B (en) | One kind is for hemodialysis pipeline modified PVC pellet | |
JPH03505600A (en) | plasticized polymer composition | |
JPH02209150A (en) | Blood or transfusion treating member | |
JP2002238976A (en) | Medical instrument | |
JP3447391B2 (en) | Medical equipment | |
CN106267376A (en) | A kind of medical catheter preparation method of super hydrophilic antimicrobial coating |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20051206 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20061114 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070105 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070330 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20070528 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20070531 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20070925 |